Dr. Chen Jiao is a Deputy Chief Physician and Associate Director of the international medical Department at Beijing Jingdu Children’s Hospital, Holds an MD in Pediatrics from the eight-year program at Peking University Health Science Center, Completed doctoral training in Peking University People's Hospital, has dedicated over a decade to advancing treatments for pediatric hematological diseases and immune deficiencies. Has published over 50 papers and abstracts in journals or academic conferences, including SCI articles, and had oral presentations at numerous national and international academic conferences.
Associate Director of the International Medical Department at Beijing Jingdu Children’s Hospital
Youth Member of the Pediatric Oncology Professional Committee of the Chinese Research Hospital Association.
Fifth Term Committee Member of the Obstetrics and Gynecology Hospital Branch of the Chinese Hospital Association.
Member of the Tumor Patient Care Working Committee of the China Population Culture Promotion Association.
Member of the Gynecological Endocrinology Branch of the Beijing Obstetrics and Gynecology Association.
Standing Committee Member of the Pediatrics Branch of the Professional Committee of the Changping District Medical Association of Beijing.
Member of the Integrated Oncology Professional Committee of the World Federation of Chinese Medicine Societies.
"Compassionate Expert" Award, China Charities Aid Foundation for Children
“Medical Advisor”, Dear Baby Pediatric Leukemia Mutual Aid Alliance
“Champion”, 2018 National Youth Physician Health Science Popularization Speech Competition (North China Division)
M.D. in Pediatrics, Peking University (Eight-Year Program)
Specialized in pediatric hematology and oncology under mentorship of Prof. Zhang Leping, a renowned expert in childhood leukemia
Completed clinical rotations at Peking University People’s Hospital and Beijing Children’s Hospital
Dr. Chen’s expertise spans diagnosis, chemotherapy, and transplantation for complex pediatric hematologic disorders:
1. Hematologic Malignancies:
Leukemia/Lymphoma: ALL, AML, refractory lymphoma,etc
2. Bone Marrow Failure & Immune Disorders:
Severe Aplastic Anemia, Shwachman-Diamond Syndrome, Fanconi anemia,etc
Wiskott-Aldrich Syndrome (WAS), Severe Combined Immunodeficiency (SCID), Chronic Granulomatous Disease（CGD）, Severe Congenital Neutropenia(SCN),etc
Hemophagocytic Lymphohistiocytosis (HLH)
Chronic Active Epstein-Barr Virus Infection (CAEBV)
3. HSCT Innovations:
Pioneered infant-specific transplant protocols addressing unique challenges like low body weight and immature organ systems （The youngest baby who completed stem cell transplantation was only 2 months old, and the baby with the lowest weight for stem cell transplantation was 3.8 kg.）
Specializes in cord blood and haploidentical transplants
Umbilical cord blood infusion for the treatment of autism
Protection of Fertility and Ovarian Endocrine Function Before Hematopoietic Stem Cell Transplantation
Transplant Technology Optimization:
1. Studied immune reconstitution patterns post-HSCT in immunodeficiencies
2. Monitoring of Growth and Development After Hematopoietic Stem Cell Transplantation in Infants and Young Children
3. Strategies for Preventing Relapse After Hematopoietic Stem Cell Transplantation for Leukemia
4. Fertility Protection Before Hematopoietic Stem Cell Transplantation
5. Prevention and Management of Various Complications After Transplantation
Mandarin and Professional English
High Patient Volume: Consistently manages complex HSCT cases, reflecting strong referrals
Award Recognition: The "Compassionate Expert" title highlights her empathetic patient-family communication
Social Media Engagement: Over 10,000 followers on her blog actively seek her advice, with comments praising her "clear explanations" and "relentless advocacy for children’s health"
EN
CN
